Evidence map›Paper›PMID 26904160›Full record

ReviewOxidative medicine and cellular longevity2016

Use of Carnosine for Oxidative Stress Reduction in Different Pathologies.

V D Prokopieva, E G Yarygina, N A Bokhan, S A Ivanova

Registry-linked trialOpen access · hybridAbstract readReview
In one paragraph

Review in Oxidative medicine and cellular longevity, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04661267 (A Randomized, Double-Blind, Placebo-Controlled Trial of Regenexx Stem Cell Support Formula), which is not on this map. Cited by 56 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed, 1 pooled it
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04661267 nacompletednot on this mapstarted 2021, after this paper: background citation

A Randomized, Double-Blind, Placebo-Controlled Trial of Regenexx Stem Cell Support Formula

TypeinterventionalSponsorRegenexx, LLCRan2021 to 2022Enrolled80ConditionsKnee OsteoarthritisArmsStem Cell Support Formula, Placebo
3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 1 synthesis or guideline pooled it, 128 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

V D ProkopievaDepartment of Biological Psychiatry and Narcology, Mental Health Research Institute, Tomsk 634014, Russia.
E G YaryginaDepartment of Biological Psychiatry and Narcology, Mental Health Research Institute, Tomsk 634014, Russia.
N A BokhanAddictive States Department, Mental Health Research Institute, Tomsk 634014, Russia.
S A IvanovaDepartment of Biological Psychiatry and Narcology, Mental Health Research Institute, Tomsk 634014, Russia.
Mental Health Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences · RUMental Health Research Institute · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The main properties and biological effects of the antioxidant carnosine, the natural dipeptide β-alanyl-L-histidine, are considered. Data on the effective use of carnosine in different pathologies are presented. Special attention is paid to issues of use of carnosine in neurologic and mental diseases, in alcoholism as well as in physiological states accompanied by activation of free-radical processes and formation of oxidative stress.

Indexed as

DiseaseAlcoholismAnimalsAntioxidantsCarnosineHumansMental DisordersOxidative StressAntioxidantsCarnosine

Identifiers

PMID26904160
PMCPMC4745351
OpenAlexW2264463083

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.